depression

plan B fail reroute road path trail miss
Biotech

Neumora rethinks depression drug strategy after ph. 3 failure

Neumora has halted one trial of navacaprant and paused another pair of late-stage studies as it tries to learn from a recent phase 3 failure.
James Waldron Mar 3, 2025 11:00am
forest woods paths paths diverge

Supernus depression drug candidate fails midstage trial

Feb 19, 2025 6:40am
colorful brain art model

Irish biotech's inhaled drug reduces depression in phase 2 trial

Feb 3, 2025 8:15am
A puzzle of the brain with one missing piece

Takeda regains home rights to depression drug from Neurocrine

Jan 28, 2025 4:16am
dart board miss failure

Neumora's dig into phase 3 depression data disappoints analysts

Jan 15, 2025 9:35am
failure crash no fail rocket cancelled end

Neumora fails phase 3 depression trial, sending stock down 80%

Jan 2, 2025 9:17am